Miami Shareholder Scott J. Bakal authored an Op-Ed for Israel’s economic journal Globes. Relevant for U.S. citizens, Israelis with children in the U.S., or who own assets there, the article discusses different implications of the imminent changes in U.S. tax law.
Member of the firm’s Tax and Private Wealth groups, Scott is also part of
| Go-To Guide: |
| The Corporate Transparency Act took effect Jan. 1, 2024, requiring non-exempt U.S. entities and non-exempt foreign entities registered to do business in the United States (collectively, Reporting Companies) to submit beneficial ownership information. (BOI) reports to a confidential FinCEN database. BOI reports must include certain personal information about individuals who, directly or indirectly, |
| Go-To Guide: |
| President Biden’s wide-ranging Oct. 30 executive order (EO) on artificial intelligence (AI) means that companies using AI or making AI products should stay current on a wave of new government regulations and guidance in the coming year.Review upcoming best practice guidance addressing specific industries to be aware of what customers (including the government) |
Greenberg Traurig’s Tel Aviv office recently hosted an official delegation from Miami-Dade county as part of their visit to Israel.
The 60-person delegation, led by Hon. Daniella Levine- Cava, the first Jewish Woman mayor of Miami-Dade, visited GT’s office in Tel Aviv and met with our local team of attorneys. In addition, we were honored
Congratulations to Memic Innovative Surgery (“Memic”), an Israeli medical device company dedicated to transforming robot-assisted surgery with its proprietary technology, on completing a multimillion dollar Series D Financing Round.
Leading GT’s team as US Counsel for Memic were Bob Grossman, Chair of Greenberg Traurig’s Israel Practice; and Miami Corporate Attorney Maria Walker
Congratulations to our client Chemomab Therapeutics (“Chemomab”) on completing a merger with public company Anchiano Therapeutics. The combined company now goes by Chemomab Therapeutics Ltd. and is traded on Nasdaq under the symbol “CMMB”. Chemomab is an Israeli, clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high
Congratulations to GT clients Theranica, Quali Systems, and Alcide.IO on their recent achievements:
Robert (Bob) L. Grossman, Chair of Greenberg Traurig’s Israel Practice and senior M&A and financing attorney at the firm’s Miami office will be moderating a session as part of the Florida-Israel Agriculture Innovation Summit. The summit, hosted by the Florida-Israel Business Accelerator (FIBA) and Florida Department of Agriculture and Consumer Services (FDACS), will
As part of their free Lunch & Learn speaker series, Jewish National Fund-USA (JNF-USA) will be hosting a discussion about innovation in the realms of biotechnology, pharmaceuticals, and agricultural technology on Tuesday, November 10, 2020, from 12:00-1:15 PM (ET). The event will feature experts from the U.S. and Israel for an audience of medical professionals,
Global law firm Greenberg Traurig, LLP was ranked in the legal category of the Chambers and Partners 2019 FinTech Guide in both U.S. and Japan jurisdictions. In addition, the following shareholders were listed as notable practitioners: